Amyris Biotechnologies Raises $20 M in Series A Funding

Emeryville, California [] Amyris Biotechnologies, Inc., a privately held company applying advances in synthetic biology to produce biofuels (as well as pharmaceuticals and chemicals), has raised $20 million in a first round of venture funding, led by Khosla Ventures, with additional participation from Kleiner Perkins Caufield & Byers (KPCB) and Texas Pacific Group Ventures (TPGV). The company’s primary project to date has focused on the use of synthetic biology in an anti-malarial drug.
Previous articleCanadian Hydro to Acquire Vector Wind Energy
Next articleGS CleanTech Installs Corn Oil Extraction Technology

No posts to display